Biolidics Limited Stock: price and insider trades · Singapore
No insider purchase over the last 90 days. The latest, by Yuan Zhi Jun, was filed 08 Aug 2025.
Biolidics Limited: what insiders have been doing
Every trade that managers of Biolidics Limited disclose to SGX is tracked on this page. In the past year (26 October 2025 to 26 October 2026), 2 filings came from 1 insider.
There is no open-market purchase to report; the filings show 1 sale worth €1.7M by 1 insider. The largest single trade was a sale of €1.7M by Wu Kun Wei, published on 8 December 2025.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 394 companies) published 6 filings over the same period, against 2 filings here. Looking back to 2018, when coverage begins, insiders filed 12 purchases and 11 sales.
Source: insider filings from SGX. Past trades are no guide to future returns.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 84,000,000 shares@ SGD 0.03100.0% of flowShareSGX-STISIN SGXE89830751SGX:VCKVG56I1CSNN53E
- 168,008,400 sharesShareSGX-STISIN SGXE89830751SGX:XHHMEDQ59TJNS41Y
- 148,391,600 shares@ SGD 0.021100.0% of flowShareSGX-STISIN SGXE89830751SGX:2PMGH3F2OWVE0HKN
- 35,000,000 sharesShareSGX-STISIN SGXE89830751SGX:ME5JVJ1OK20FVADICanonical exit: 6 Nov 2025 (T+90)
- ShareSGX-STISIN SGXE89830751SGX:3ZN9MC9GZT9ROYHI
- ShareSGX-STISIN SGXE89830751SGX:RJAN192GREPX1AY7
- 148,391,600 sharesShareSGX-STISIN SGXE89830751SGX:Q2WFK2I7Y5Q0TL5M
- 148,391,600 sharesShareSGX-STISIN SGXE89830751SGX:YADPN4MJDAM11JRACanonical exit: 5 Jan 2025 (T+90)
- 168,008,400 sharesShareSGX-STISIN SGXE89830751SGX:BEKMGR90T5LBIF74Canonical exit: 5 Jan 2025 (T+90)
- ShareSGX-STISIN SGXE89830751SGX:QTQ7IQ6FCK9O9WY3
- 407,000,000 shares@ SGD 0.00458.7% of flowShareSGX-STISIN SGXE89830751SGX:H5ISBVV4KABYIP0CCanonical exit: 1 Jan 2025 (T+90)
- 7,500,000 shares@ SGD 0.01230.5% of flowShareSGX-STISIN SGXE89830751SGX:XZ2HVYJJ6VZPUM75
- 83,000,000 shares@ SGD 0.0121100.0% of flowShareSGX-STISIN SGXE89830751SGX:W4I3K0N5KDTTXDG3Canonical exit: 11 Apr 2024 (T+90)
- 12,879,800 shares@ SGD 0.015969.5% of flowShareSGX-STISIN SGXE89830751SGX:7BPX78DCYUA05SWX
- ShareSGX-STISIN SGXE89830751SGX:7JOESCM7CXP6ESD7
- 98,500,000 shares@ SGD 0.011941.3% of flowShareSGX-STISIN SGXE89830751SGX:DEAXLECJP9LOFLNLCanonical exit: 27 Feb 2024 (T+90)
- 57,123,300 shares@ SGD 0.0163100.0% of flowShareSGX-STISIN SGXE89830751SGX:Y4EAZ3TDZE4775OMCanonical exit: 22 Oct 2023 (T+90)
- 57,123,300 shares@ SGD 0.016390.8% of flowShareSGX-STISIN SGXE89830751SGX:DD42U6RGIZPODFLR
- 23,725,700 sharesShareSGX-STISIN SGXE89830751SGX:WQKW5BZPQIRPTPLACanonical exit: 30 May 2023 (T+90)
- 37,500,000 sharesShareSGX-STISIN SGXE89830751SGX:ROC8OA3530AJZDI5Canonical exit: 18 Jun 2023 (T+90)
- 23,725,700 sharesShareSGX-STISIN SGXE89830751SGX:25DKKIESR9Y7B9I5Canonical exit: 30 May 2023 (T+90)
- 46,019,300 sharesShareSGX-STISIN SGXE89830751SGX:ZE0XJIQ3DT6HRXPV
- ShareSGX-STISIN SGXE89830751SGX:B205LGPJLPP8OJZC
- 2,748,300 sharesShareSGX-STISIN SGXE89830751SGX:ACOWGY0PX31DQTY9
- 775,800 shares@ SGD 0.005100.0% of flowShareSGX-STISIN SGXE89830751SGX:67UWNS4RW25IDPYW
25 of 46 declarations
About Biolidics Limited
Biolidics Limited is a company listed on the XSES market, specializing in the development of medical diagnostic solutions. It focuses on innovation in the healthcare sector.